Patent classifications
A61K2236/15
METHOD OF MANUFACTURING A VAPORIZABLE TABLET FOR USE IN AN ATOMIZER
Various embodiments of the present technology may provide a method of manufacturing a vaporizable tablet for use in an atomizer of a vaporizer device. The method may include grinding a vaporizable material and treating the ground vaporizable material with a mixture comprising an aerosol forming agent and at least one binding agent. The method may also include conditioning or thermally treating the vaporizable material in a sealed enclosure or open environment for a time period. The method may further include forming the tablet utilizing the treated, conditioned vaporizable material.
PLANT EXTRACT HIGHLY CONCENTRATED IN SAFRANAL, PRODUCTION METHOD AND USES THEREOF
The invention concerns a plant extract obtained from saffron, with a safranal concentration, measured using the HPLC method, of a minimum of 0.2% in weight relative to the total dry matter weight. The invention also concerns a procedure for obtaining such an extract, as well as compositions including this extract, and its use.
A PROCESS TO ENHANCE THE BIOACTIVITY OF ASHWAGANDHA EXTRACTS
The invention relates to an extract of Ashwagandha that exhibit enhanced bioactivity and bioavailability comprising of enriched withanolide glycosides and saponins; with negligible amount of alkaloids, withanolide aglycones and oligosaccharides. The extract as disclosed prepared from root, stems, leaves and whole plant of Ashwagandha further shows improved immunomodulatory activity, anti-inflammatory activity, anti stress activity, antidiabetic activity and sleep quality. The disclosure also provides a method of improving bioactivity of withanolide glycosides even at lower doses, by the administration of an enteric coaled formulation of extract of Ashwagandha to humans. The enteric coaling protects the composition from hydrolysis in the acidic environment of the stomach to release the withanolide glycoside in neutral/alkaline pH in gastrointestinal tract (GIT) thus enhancing the absorption. Further the process of preparation of the extract of Ashwagandha enriched with withanolide glycosides and saponins are disclosed along with various formulations.
ANTIDEPRESSANT FOOD AND METHOD FOR PREPARING THE SAME
An antidepressant food and a method for preparing the same are provided. The antidepressant food includes, by mass percentage, Semen ziziphi spinosae powder in a range of 28% to 36%, γ-aminobutyric acid in a range of 10% to 15%, theanine in a range of 15% to 20%, phosphatidylserine in a range of 10% to 20%, Ficus tikoua extract in a range of 8% to 14%, Huperzia serrata extract in a range of 10% to 16%, sucralose in a range of 0.5% to 1% and fruit essence in a range of 0.5% to 1.5%.
Injectable psychoactive alkaloid composition and preparation thereof
The liquid composition includes a psychoactive alkaloid extract or synthetic psychoactive alkaloid. The alkaloids in the extract are predominantly dephosphorylated rather than phosphorylated. The injectable psychoactive alkaloid composition includes a carrier, an optional tonicity modifier, an optional antioxidant or preservative, an optional pH modifier, and optional further excipients. A process for obtaining an injectable psychoactive alkaloid composition includes dephosphorylating the alkaloid during extraction, purifying the extracted alkaloid, and standardizing it to a specific concentration by adding measured quantities of excipients.
COSMETIC COMPOSITION FOR IMPROVING ANTI-OXIDATION, ANTI-INFLAMMATION AND ATOPIC SKIN BY USING FERMENTED BLACK TEA LIQUID AS EFFECTIVE INGREDIENT AND METHOD OF PREPARING THE SAME
Disclosed are a cosmetic composition for improving anti-oxidation, anti-inflammation and atopic skin by using fermented liquid of black tea as an effective ingredient and a method of preparing the same. The cosmetic composition includes the fermented black tea liquid obtained by primarily fermenting black tea with saccharomyces, secondarily fermenting the black tea with gluconacetobacter and tertiarily fermenting the black tea with bacillus.
Smokeless cannabis composition and method of manufacture
A cannabis composition includes a cannabis material and an additive solution. Cannabis material includes flowers, sugar leaves, and fan leaves from a cannabis plant, and can be configured to be finely cut or coarsely cut. An additive solution includes honey and a cannabis extract. Further disclosed is a method of manufacture of a cannabis composition, including a method for allowing a cannabis composition to ferment and a method of heating a cannabis composition.
SYSTEMS, METHODS, AND EQUIPMENT FOR CHEMICAL EXTRACTION
Novel thermal evaporative processes for the recovery of heat-sensitive constituents, raw essential oil concentrates, and other compounds from plant biomass material are disclosed, as are systems for implementing such processes. Particularly, the processes include a solvent-less process for either batch-wise or continuous removal and recover), of refined oils, such as volatile aroma components and heavier oils, from plant material.
331 NEW FOUND PROTEINS IN PEANUT WITH THEIR SEQUENCE AND THE METHOD OF PRODUCING SUPPLEMENT INCLUDING BEVERAGES ON THE BASIS OF JUICE AND POWDER FROM THE PEANUT
331 new found proteins in peanut with their sequence and the method of producing supplement including beverages on the basis of juice and powder from the peanut. 490 new found proteins in cashew sequence and method of producing food supplements including beverages on the basis of juice and powder from the cashew. 843 new found proteins in edamame (young soy) sequence and method of producing food supplement including beverages on the basis of juice and powder from the edamame (young soy)
METHOD OF TREATING HYPERTENSION
A method of treating hypertension can include administering to a patient in need thereof a therapeutically effective amount of an extract of Matricaria chamomilla L. The extract can be administered orally to the patient in an amount of about 100 mg/kg to about 200 mg/kg.